Clinical trials
Phase 2/3 Squamous Cell Carcinoma of Head and Neck trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bicara Therapeutics | 1 |
| BioNTech SE | 1 |
| Exelixis | 1 |
| Inhibrx Biosciences, Inc | 1 |
| Nektar Therapeutics | 1 |
| Sesen Bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Head and Neck Neoplasms | 5 |
| Mouth Neoplasms | 2 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma, Squamous Cell | 1 |
| Hypopharyngeal Neoplasms | 1 |
| Laryngeal Diseases | 1 |
| Laryngeal Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms, Squamous Cell | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.